Abstract
Podocyte calcium (Ca2+) signaling plays important roles in the (patho)physiology of the glomerular filtration barrier. Overactivation of podocyte transient receptor potential canonical (TRPC) channels including TRPC6 and purinergic signaling via P2 receptors that are known mechanosensors can increase podocyte intracellular Ca2+ levels ([Ca2+]i) and cause cell injury, proteinuria and glomerular disease including in diabetes. However, important mechanistic details of the trigger and activation of these pathways in vivo in the intact glomerular environment are lacking. Here we show direct visual evidence that podocytes can sense mechanical overload (increased glomerular capillary pressure) and metabolic alterations (increased plasma glucose) via TRPC6 and purinergic receptors including P2Y2. Multiphoton microscopy of podocyte [Ca2+]i was performed in vivo using wild-type and TRPC6 or P2Y2 knockout (KO) mice expressing the calcium reporter GCaMP3/5 only in podocytes and in vitro using freshly dissected microperfused glomeruli. Single-nephron intra-glomerular capillary pressure elevations induced by obstructing the efferent arteriole lumen with laser-induced microthrombus in vivo and by a micropipette in vitro triggered >2-fold increases in podocyte [Ca2+]i. These responses were blocked in TRPC6 and P2Y2 KO mice. Acute elevations of plasma glucose caused >4-fold increases in podocyte [Ca2+]i that were abolished by pharmacological inhibition of TRPC6 or P2 receptors using SAR7334 or suramin treatment, respectively. This study established the role of Ca2+ signaling via TRPC6 channels and P2 receptors in mechanical and metabolic sensing of podocytes in vivo, which are promising therapeutic targets in conditions with high intra-glomerular capillary pressure and plasma glucose, such as diabetic and hypertensive nephropathy.
Introduction
Glomerular podocytes in the kidney play major roles in the maintenance of the structure and function of the healthy glomerular filtration barrier (GFB) and in the development of glomerular pathologies [1]. Among the many molecular players of the podocyte slit diaphragm component of the GFB, transient receptor potential canonical (TRPC) channels including TRPC6 and purinergic P2 receptors including P2Y2 have been identified as key mechanisms in the regulation of podocyte intracellular Ca2+ levels ([Ca2+]i), development of cell injury, proteinuria and glomerular disease [2–8]. As part of their overall function, podocyte TRPC6 channels and P2 receptors (e.g. P2X4) have been initially suggested [9, 10] and subsequently confirmed experimentally using in vitro cell models [11–14] to act as molecular mechanosensors in the slit diaphragm that help maintain normal podocyte structure and function, but may also lead to disease development. While the mechanosensing hypothesis fits well with known functions of the podocyte slit diaphragm and with the molecular characteristics of TRPC6 and P2 receptors [15, 16], convincing in vivo studies have been lacking. In addition, a similarly untested metabolic sensory function of podocytes via TRPC6 and P2 receptors in vivo may add to the ability of podocytes to sense and respond to alterations in their local tissue environment [5, 17].
Due to the inaccessibility of podocytes and the 3D complexity of the GFB, podocytes have been traditionally difficult to study in their native environment in vivo. However, a new intravital imaging approach has been developed and applied recently to shed new light on podocyte functions including [Ca2+]i signaling [2, 18, 19]. This direct visual approach employs intravital multiphoton microscopy (MPM) combined with new genetic mouse models for fluorescent podocyte labeling and tagging [2, 20, 21].
The present study aimed to test the mechanical and metabolic sensory function of podocytes in vivo by quantitatively visualizing the dynamic effects of high intra-glomerular capillary pressure as a solely mechanical stimulation, and increased plasma glucose levels as a metabolic stimulus on podocyte [Ca2+]i. In combination with genetic and pharmacological approaches, we also addressed the hypothesis that TRPC channels including TRPC6 and P2 purinoceptors including P2Y2 play important roles in podocyte mechano and metabolic sensing.
Materials and methods
Animals
Male and female, 4–8 weeks old wild-type (WT), TRPC6 and P2Y2 knockout (KO) C57BL6/J mice (Jackson Laboratory, Bar Harbor, ME) were used in all experiments. Pod-GCaMP3(G3) or GCaMP5(G5) fluorescent reporter mice, which specifically express the intensely green and calcium-sensitive fluorescent protein GCaMP3 or GCaMP5, and the calcium insensitive red fluorescent dye tdTomato in podocytes (only with GCaMP5) were generated by crossing mice expressing Cre recombinase under the control of the podocin promoter [22] and GCaMP3flox or GCaMP5flox mice [23, 24]. Pod-G3/G5 fluorescent reporter mice were further backcrossed with TRPC6 [25] and P2Y2 KO mice [2, 26]. All mice were purchased from the Jackson laboratory. Some mice received intravenous glucose (4 g kg−1 in 50 µL PBS, NIST917C Sigma Aldrich, St. Louis, MO), or equimolar mannitol (PHR1007, Sigma Aldrich, St. Louis, MO) or the purinergic receptor blocker Suramin (50 mg kg−1 bolus followed by 150 mg kg−1 h−1 maintenance dose into the cannulated carotid artery, S2671, Sigma Aldrich, St. Louis, MO) injection, or the selective TRPC6 inhibitor SAR7334 (10 mg kg−1 in 50 µL, 5,831 Tocris, Minneapolis, MN) via oral gavage. All animal protocols were approved by the Institutional Animal Care and Use Committee at the University of Southern California.
Tissue processing, histology and immunofluorescence
Immunofluorescence detection of proteins was performed as described previously [27]. Briefly, kidneys were perfused and fixed in 4% PFA for 2 h at room temperature, embedded in paraffin, and sectioned 8 µm thick. For immunofluorescence analysis of antibody stains, slides were washed in 1XPBS. For antigen retrieval, heat-induced epitope retrieval with Sodium Citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0) was applied. To reduce non-specific binding, sections were blocked with normal serum (1:20). Primary and secondary antibodies were applied sequentially overnight at 4º C and 2 h at room temperature. Primary antibodies and dilutions were as follows: anti-TRPC6 antibody (1:100, ACC-120, Alomone Labs, Jerusalem, Israel), anti-P2Y2 antibody (1:100, APR-010, Alomone Labs, Jerusalem, Israel), anti-GFP antibody (GFP 1:200 Thermo Fisher Scientific, Waltham, MA). Alexa Fluor 488 and 594-conjugated secondary antibodies were purchased from Invitrogen (Waltham, MA). Slides were mounted by using DAPI-containing mounting media (VectaShield, Vector Laboratories Inc., Burlingame, CA). Sections were examined with Leica TCS SP8 (Leica Microsystems, Wetzlar, Germany) confocal/multiphoton laser scanning microscope systems as described previously [27, 28].
Intravital imaging using multiphoton microscopy (MPM)
Under continuous anesthesia (Isoflurane 1–2% inhalant via nose-cone), mice were placed on the stage of the inverted microscope with the exposed kidney mounted in a coverslip-bottomed chamber bathed in normal saline as described previously [29, 30]. Body temperature was maintained with a homeothermic blanket system (Harvard Apparatus). Alexa Fluor 594 or 680-conjugated albumin (Thermo Fisher, Waltham, MA) was administered iv. by retro-orbital injections to label the circulating plasma (30 µL iv. bolus from 10 μg mL−1 stock solution). The images were acquired using a Leica SP8 DIVE multiphoton confocal fluorescence imaging system with a 40 × Leica water-immersion objective (numerical aperture (NA) 1.2) powered by a Chameleon Discovery laser at 860 nm or 960 nm (Coherent, Santa Clara, CA) and a DMI8 inverted microscope’s external Leica 4Tune spectral hybrid detectors (emission at 510–530 nm for GCaMP3 and 5, at 580–640 nm for tdTomato and AF594, and at 680–740 for AF680) (Leica Microsystems, Heidelberg, Germany). The potential toxicity of laser excitation and fluorescence to the cells was minimized by using a low laser power and high scan speeds to keep total laser exposure as minimal as possible. Fluorescence images were collected in volume and time series (xyt, 526 ms per frame) with the Leica LAS X imaging software and using the same instrument settings (laser power, offset, gain of both detector channels). The strong, positive, cell-specific signal (GCaMP3/5 – tdTomato fluorescence) and high-resolution MPM imaging allowed for easy identification of single podocyte cell bodies and processes. Acute intra-glomerular pressure elevation was induced by focusing the laser beam on a small focal point at the periphery of an endothelial cell in the efferent arteriole (EA) (approximately 1-μm × 1-μm square-shaped ROI scan for 1 s at 20% laser power) to induce well-controlled and localized injury of a single endothelial cell resulting in microthrombi formation and obstruction of EA blood flow [31].
In vitro isolated and microperfused glomerulus
Individual glomeruli with attached afferent (AA) and efferent (EA) arterioles were dissected freehand from freshly harvested kidneys of anesthetized mice and perfused in vitro using methods that were described before [32]. Briefly, the AA was cannulated and microperfused. Viability of each preparation was confirmed by the existence of small, spontaneous, and temporary vasoconstrictions in the AA. Dissection media were prepared from DMEM mixture F-12 (Sigma-Aldrich). Fetal bovine serum (Hyclone) was added at a final concentration of 3%. Arteriole perfusion and bath fluid was a modified Krebs-Ringer-HCO3 buffer containing (in mM) 110 NaCl, 25 NaHCO3, 0.96 NaH2PO4, 0.24 Na2HPO4, 5 KCl, 1.2 MgSO4, 2 CaCl2, 5.5 d-glucose, and 100 μM l-arginine. The pH of the solutions was adjusted to 7.4. Each preparation was transferred to a thermoregulated Lucite chamber mounted on an inverted microscope (Leica TCS SP8, 63× glycerol immersion objective). The preparation was kept in the dissection solution, and also, temperature was kept at 4 °C until cannulation of the arteriole was completed and then gradually raised to 37 °C for the remainder of the experiment. The bath was continuously exchanged (1 mL min−1) and oxygenized (95% O2–5% CO2) throughout the whole experiment. Elevations in glomerular capillary pressure was triggered by obstructing the EA lumen by pressing down the EA with a glass micropipette with the help of a micromanipulator (MP-225; Sutter Instrument, Novato, CA), while maintaining AA perfusion pressure (50 mmHg) constant as described before [32].
Quantification of GCaMP3/5 fluorescence intensity
An optical section including a glomerulus was selected and time (xyt) series with 1 frame per 526 ms were recorded for 2–15 min to measure [Ca2+]i dynamics. The strong, positive signal (GCaMP3 and GCaMP5/tdTomato fluorescence) and high-resolution MPM imaging allowed for easy identification of single podocytes. For the quantification of changes in mean GCaMP3 and 5 fluorescence intensity, ROIs were drawn closely over the total cell body of single podocytes or over the entire glomerulus and the changes in GCaMP3/5 Fmax/F0 (green channel; fluorescence intensity expressed as a ratio relative to baseline) were measured after the experiment in the defined ROI using the Quantify package of LAS X software (3.6.0.20104; Leica-Microsystems) as described before [2].
Statistical methods
Data are expressed as average ±SEM and were analyzed using Student’s t-tests (between two groups), or ANOVA (for multiple groups) with post-hoc comparison by Bonferroni test. P < 0.05 was considered significant. Statistical analyses were performed using GraphPad Prism 9.0.1 (GraphPad Software, Inc.).
Results
Mechanosensation by podocytes in vivo and in vitro
These studies performed time-lapse high resolution multiphoton microscopy (MPM) of the intact living kidney of WT, and TRPC6 or P2Y2 knockout (KO) Pod-GCaMP3 or Pod-GCaMP5 mice to directly and quantitatively visualize changes in podocyte [Ca2+]i in the local glomerular tissue environment in vivo. TRPC6 and P2Y2 deficiency was confirmed by immunohistochemistry in TRPC6 and P2Y2 KO mice, respectively, compared to their WT littermates (Fig. 1A). All mice featured the genetically expressed Ca2+-sensitive reporter, either GCaMP3 alone or GCaMP5 (both green) together with the Ca2+-insensitive tdTomato (red) specifically in podocytes, driven by the podocin (Pod) promoter in a Cre-lox system (Fig. 1B). In this study, glomeruli of cortical nephrons approximately 150 µm under the kidney surface were visualized. Figure 1B demonstrates that a great number (>50) of superficial glomeruli were available for MPM imaging. On close-up images, individual GCaMP expressing podocytes with their cell processes were visible in great detail (Fig. 1B).
We first used MPM imaging of Pod-GCaMP3 mice in vivo and devised a maneuver to generate glomerular capillary pressure elevations acutely in single nephrons by obstructing the blood flow of the efferent arteriole (glomerular outflow) with a laser-induced microthrombus in the vessel lumen (Fig. 2A, Supplement Movie 1 available at https://figshare.com/s/9d9073bc01b179742459). The observed, approximately 10% increase in glomerular capillary and tuft diameter in response to obstructing the efferent arteriole lumen indicated successfully elevated glomerular capillary pressure (Fig. 2A). Importantly, this maneuver triggered >2-fold increases in [Ca2+]i in several podocytes as compared to baseline, based on normalized changes in single cell GCaMP3 fluorescence intensity as an indicator for podocyte [Ca2+]i changes (Fig. 2B). Capillary pressure-induced podocyte [Ca2+]i elevations were blocked in TRPC6 (0.84 ± 0.08-fold) and P2Y2 KO mice (0.86 ± 0.05-fold) compared to WT (2.09 ± 0.18-fold, P < 0.05, 2 glomeruli/mouse from n = 5 mice in each group) (Fig. 2B). In addition, the presence and magnitude of these podocyte [Ca2+]i responses were confirmed using the Pod-GCaMP5/tdTomato mouse model. The same capillary pressure elevation maneuver triggered similar, 2.23 ± 0.17-fold podocyte [Ca2+]i elevations (n = 6, data not shown). Simultaneous increases in [Ca2+]i in numerous distant podocytes indicated the presence of primary responses to pressure elevation, while some podocytes triggered cell-to-cell propagating [Ca2+]i waves (Fig. 2A and C, Supplement Movie 1). In response to this maneuver, albumin leakage through the GFB developed as evident by the appearance of labeled albumin in the Bowman’s space. Interestingly, GFB albumin leakage preceded podocyte [Ca2+]i elevations (Fig. 2C, Supplement Movie 1).
To confirm capillary pressure-induced elevations in podocyte [Ca2+]i in a model that is free of potential non-specific influences by alterations in systemic or the local microthrombotic environment, we next used freshly dissected and microperfused glomeruli in vitro from the same mouse models (Fig. 3A–D, Supplement Movie 2, available at https://figshare.com/s/9d9073bc01b179742459z). In this model, glomerular capillary pressure elevations were induced by obstructing the efferent arteriole outflow with a micropipette while afferent arteriole perfusion was maintained constant. This maneuver caused on average an 8–10% increase in glomerular capillary and tuft diameter, which was uniform in all experimental groups (Fig. 3D). In response to glomerular capillary pressure elevations, podocyte GCaMP3 fluorescence intensity significantly increased in several but not all podocytes in preparations from WT mice (2.20 ± 0.04-fold) (Fig. 3A–C). Podocyte [Ca2+]i responses were diminished in preparations from TRPC6 KO (1.04 ± 0.01-fold) and P2Y2 KO mice (1.09 ± 0.01-fold, P < 0.05, n = 10 in each group) (Fig. 3C, Supplemental Video 2).
Metabolic (glucose) sensing by podocytes in vivo
To test whether podocytes can sense metabolic signals via [Ca2+]i in vivo, specifically increased plasma glucose as seen in diabetes, Pod-GCaMP5/tdTomato mice were subjected to acute plasma glucose loading that resulted in plasma glucose levels uniformly at 500 ± 50 mg dL−1. To control for elevated plasma osmolality, equimolar mannitol infusions were performed. Acute hyperglycemia caused elevations in [Ca2+]i in all podocytes in untreated WT mice with a biphasic response, a robust peak (4.20 ± 0.16-fold elevation) followed by a prolonged plateau (1.53 ± 0.09-fold elevation). In contrast, hyperglycemia-induced podocyte [Ca2+]i responses were diminished in mice pre-treated with the selective TRPC6 inhibitor SAR7334 (1.37 ± 0.19 and 1.13 ± 0.08-fold increases in peak and plateau, respectively) or with the purinergic P2 receptor blocker suramin (2.44 ± 0.36 and 1.17 ± 0.08-fold increases in peak and plateau, respectively). Compared to high glucose, equimolar mannitol plasma loading did not produce elevations in podocyte [Ca2+]i in untreated WT mice (1.16 ± 0.08 and 0.98 ± 0.04-fold increases in peak and plateau, respectively).
Discussion
This study applied intravital MPM imaging combined with genetic and pharmacological inhibition of TRPC6 calcium channels and P2 purinergic receptors to uncover novel mechanistic insights of podocyte mechanical and metabolic sensing. Direct in vivo visual evidence was presented to support podocyte mechanosensitivity, specifically the ability of podocytes to directly detect and respond to elevations in intra-glomerular capillary pressure via [Ca2+] signaling that involved TRPC6 calcium channels and P2Y2 purinergic receptors. In addition, podocytes showed extremely high sensitivity to alterations in the systemic metabolic environment, specifically increased plasma glucose levels that triggered even higher [Ca2+] elevations that similarly involved TRPC6 calcium channels and P2 purinergic receptors. These key findings provide further confirmation, at the in vivo level, that podocyte [Ca2+] signaling via TRPC6 calcium channels and P2 receptors play important pathological roles in podocyte and glomerular injury and disease.
Intravital MPM imaging performed in the present study used podocyte-specific expression of genetically encoded [Ca2+] reporters GCaMP3 as in earlier studies [2, 18, 19], as well as GCaMP5 which is an improved, more [Ca2+]i sensitive version [24]. In fact, detailed microanatomical features of podocytes including cell processes were clearly observed with MPM imaging of Pod-GCaMP5/tdTomato mice (Fig. 1B). In addition, Fig. 1B confirmed the presence of a great number of superficial glomeruli in the mouse renal cortex and their availability for performing quantitative imaging measurements such as in the present study.
The key pathogenic roles of [Ca2+]i elevations mediated by TRPC calcium channels including TRPC6 [3, 6, 8, 17] and TRPC5 [33], and purinergic receptors including P2Y2, P2X4 and others [2, 5, 13] in podocyte injury and glomerular pathologies have been well documented. Specifically, earlier fluorescence imaging studies have used cell culture or dissected glomeruli and reported podocyte [Ca2+]i responses to a variety of stimuli in vitro including mechanical load and diabetic conditions [4, 13, 17, 32–34]. Following initial proposals that TRPC6 in podocytes may play a mechanosensory role [9, 10], Dryer and co-workers showed experimentally that TRPC6 channels in cultured podocytes can be activated by many different mechanical stimuli [11, 12, 14]. Forst et al. identified the role of P2X4 in podocyte mechanosensing by measuring the effects of hypoosmolality and pipette pressure rather than directly physiologically relevant stimuli on [Ca2+]i responses of cultured podocytes [13]. Only a few studies measured podocyte [Ca2+]i responses in vivo in the intact kidney [2, 18, 19], however none of these addressed the effects of mechanical, hemodynamic or metabolic stimuli. The present study applied physiologically and pathologically relevant conditions and demonstrated increased glomerular capillary pressure (Figs 2–3) and plasma glucose-induced elevations in podocyte [Ca2+]i in vivo (Fig. 4). These findings are consistent with the mechanosensing and metabolic sensing functions and their roles in the physiological maintenance or pathological changes of these important glomerular cell types. Subsequent experiments confirmed the mechanistic role of TRPC6 calcium channels and P2 purinoceptors including P2Y2 in these podocyte functions (Figs 2 –4).
Transient elevations in podocyte [Ca2+]i in response to either acute mechanical load or high plasma glucose as demonstrated in the present experiments may be relevant and important in the physiological context. By strengthening the actin-cytoskeleton and cell adhesion, these sensory mechanisms may help podocytes counteract increased glomerular mechanical strain during blood pressure fluctuations and postprandial hyperfiltration, maintain GFB permeability and functions, and prevent podocyte detachment. However, sustained mechanical and metabolic stimuli and elevations in podocyte [Ca2+]i via gain-of-function of TRPC6 ion channels and/or P2 purinergic receptors during disease conditions play well-known major roles in podocyte injury, foot process effacement and glomerular pathology development [5, 9, 10, 13, 18]. The presently observed features of podocyte mechanosensing including heterogeneity (Figs 2–3), cell-to-cell propagation (Fig. 2A and C, Supplement Movie 1), TRPC6 channel and P2 receptor dependence of [Ca2+]i responses (Figs 2 –4) are consistent with earlier reports [2, 4, 5, 13, 18]. Interestingly, the present studies observed high capillary pressure-induced [Ca2+]i increases in several but not all podocytes (Figs 2–3). This finding is consistent with the heterogeneity of TRPC6 expression between individual podocytes including in the same glomerulus, but it could be explained also, at least partially, by the presence of different mechanical strain in different areas of glomerular capillaries (e.g. in the recently described afferent/efferent arteriole chamber [35] vs. inside a single capillary segment). Similarly heterogenous, TRPC6-dependent [Ca2+]i responses of podocytes to angiotensin II have been reported in a recent study [18]. The cell-to-cell propagating [Ca2+]i wave during glomerular capillary pressure elevation (Fig. 2A and C) is consistent with the previously described phenomenon of secondary podocyte injury [36, 37], and with the P2 receptor-mediated podocyte [Ca2+]i wave that was demonstrated in our previous intravital MPM imaging study [2]. TRPC6 channel and P2 receptor dependence of podocyte mechano and metabolic sensing found in the present work (Figs 2 –4) is in agreement with most but not all earlier works by others and further substantiates the important role of these molecular pathways in podocyte function [3–5, 18, 34]. The lack of TRPC6 dependence of podocyte mechanosensory function found in an earlier study [13] may be explained by the non-physiological stimuli and cell culture model applied in that study compared to the in vivo and (patho)physiological approaches used in the present study. It should be noted that the presently applied pharmacological inhibitors of TRPC channels (SAR7334) and purinergic P2 receptors (suramin) (Fig. 4) are non-selective antagonists of these molecular [Ca2+]i signaling pathways, although SAR7334 is fairly specific for TRPC6 [4, 38]. Therefore, we cannot exclude the possibility of other TRPC channels and/or P2 receptors contributing to podocyte mechano and metabolic sensing. While a few studies implicated the role of podocyte P2X receptors [5, 13], P2Y metabotropic purinoceptors were shown as the main purinergic Ca2+ pathway in podocytes in several prior reports [2, 7, 39] and in the present study (Figs 2–3). The finding that podocytes may be more sensitive to metabolic (high glucose, Fig. 4) compared to mechanical (high capillary pressure, Figs 2–3) stimuli is an interesting new insight relevant to diabetic vs hypertensive kidney diseases and requires further exploration in future studies.
Interestingly, we found that GFB albumin leakage preceded podocyte [Ca2+]i elevations (Fig. 2) suggesting that hemodynamic changes rather than elevations in podocyte [Ca2+]i played causative roles in albumin leakage. The role of glomerular endothelial injury and microthrombi in podocyte detachment and albumin leakage via hemodynamic and mechanical forces has been reviewed recently by our group [40]. Further support for the role of hemodynamics vs. podocyte [Ca2+]i per se was provided by acute manipulations of podocyte [Ca2+]i using intravital MPM imaging of a DREADD mouse model that found no immediate effects on podocyte or glomerular functions [19].
In summary, the present study directly demonstrated the role of Ca2+ signaling via TRPC6 channels and P2 receptors in the mechanical and metabolic sensory capacity of podocytes in vivo. These cell and molecular mechanisms are promising therapeutic targets in conditions with high intra-glomerular capillary pressure and altered systemic metabolism, such as diabetic and hypertensive nephropathy for the prevention of kidney diseases.
Acknowledgments
This work was supported in part by US National Institutes of Health grants DK100944 to J.P-P. Fluorescence imaging was performed at the USC Multi-Photon Microscopy Core funded by the National Institute of Health grant S10OD021833.
Supplementary material
Supplementary data to this article can be found online at https://doi.org/10.1556/2060.2021.00205.
References
- 1.↑
Pavenstädt H , Kriz W , Kretzler M . Cell biology of the glomerular podocyte. Physiol Rev 2003; 83(1): 253–307.
- 2.↑
Burford JL , Villanueva K , Lam L , Riquier-Brison A , Hackl MJ , Pippin J , et al. Intravital imaging of podocyte calcium in glomerular injury and disease. J Clin Invest 2014; 124(5): 2050–8.
- 3.↑
Eckel J , Lavin PJ , Finch EA , Mukerji N , Burch J , Gbadegesin R , et al. TRPC6 enhances angiotensin II-induced albuminuria. J Am Soc Nephrol 2011; 22(3): 526–35.
- 4.↑
Ilatovskaya DV , Palygin O , Levchenko V , Endres BT , Staruschenko A . The role of angiotensin II in glomerular volume dynamics and podocyte calcium handling. Sci Rep 2017; 7(1): 299.
- 5.↑
Palygin O , Klemens CA , Isaeva E , Levchenko V , Spires DR , Dissanayake LV , et al. Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys. iScience 2021; 24(6): 102528.
- 6.↑
Reiser J , Polu KR , Möller CC , Kenlan P , Altintas MM , Wei C , et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37(7): 739–44.
- 7.↑
Roshanravan H , Dryer SE . ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species. Am J Physiol Renal Physiol 2014; 306(9): F1088–97.
- 8.↑
Winn MP , Conlon PJ , Lynn KL , Farrington MK , Creazzo T , Hawkins AF , et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308(5729): 1801–4.
- 9.↑
Huber TB , Schermer B , Benzing T . Podocin organizes ion channel-lipid supercomplexes: implications for mechanosensation at the slit diaphragm. Nephron Exp Nephrol 2007; 106(2): e27–31.
- 10.↑
Möller CC , Flesche J , Reiser J . Sensitizing the slit diaphragm with TRPC6 ion channels. J Am Soc Nephrol 2009; 20(5): 950–3.
- 11.↑
Anderson M , Kim EY , Hagmann H , Benzing T , Dryer SE . Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol. Am J Physiol Cell Physiol 2013; 305(3): C276–89.
- 12.↑
Dryer SE , Roshanravan H , Kim EY . TRPC channels: regulation, dysregulation and contributions to chronic kidney disease. Biochim Biophys Acta Mol Basis Dis 2019; 1865(6): 1041–66.
- 13.↑
Forst AL , Olteanu VS , Mollet G , Wlodkowski T , Schaefer F , Dietrich A , et al. Podocyte purinergic P2X4 channels are mechanotransducers that mediate cytoskeletal disorganization. J Am Soc Nephrol 2016; 27(3): 848–62.
- 14.↑
Kim EY , Roshanravan H , Dryer SE . Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors. Biochim Biophys Acta Mol Basis Dis 2017; 1863(9): 2342–54.
- 15.↑
Welsh DG , Morielli AD , Nelson MT , Brayden JE . Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 2002; 90(3): 248–50.
- 16.↑
Kong Q , Quan Y , Tian G , Zhou J , Liu X . Purinergic P2 receptors: novel mediators of mechanotransduction. Front Pharmacol 2021; 12: 671809.
- 17.↑
Ilatovskaya DV , Blass G , Palygin O , Levchenko V , Pavlov TS , Grzybowski MN , et al. A NOX4/TRPC6 pathway in podocyte calcium regulation and renal damage in diabetic kidney disease. J Am Soc Nephrol 2018; 29(7): 1917–27.
- 18.↑
Binz-Lotter J , Jüngst C , Rinschen MM , Koehler S , Zentis P , Schauss A , et al. Injured podocytes are sensitized to angiotensin II-induced calcium signaling. J Am Soc Nephrol 2020; 31(3): 532–42.
- 19.↑
Koehler S , Brähler S , Kuczkowski A , Binz J , Hackl MJ , Hagmann H , et al. Single and transient Ca(2+) peaks in podocytes do not induce changes in glomerular filtration and perfusion. Sci Rep 2016; 6: 35400.
- 20.↑
Hackl MJ , Burford JL , Villanueva K , Lam L , Suszták K , Schermer B , et al. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat Med 2013; 19(12): 1661–6.
- 21.↑
Peti-Peterdi J , Kidokoro K , Riquier-Brison A . Novel in vivo techniques to visualize kidney anatomy and function. Kidney Int 2015; 88(1): 44–51.
- 22.↑
Moeller MJ , Sanden SK , Soofi A , Wiggins RC , Holzman LB . Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 2003; 35(1): 39–42.
- 23.↑
Zariwala HA , Borghuis BG , Hoogland TM , Madisen L , Tian L , De Zeeuw CI , et al. A Cre-dependent GCaMP3 reporter mouse for neuronal imaging in vivo. J Neurosci 2012; 32(9): 3131–41.
- 24.↑
Gee JM , Smith NA , Fernandez FR , Economo MN , Brunert D , Rothermel M , et al. Imaging activity in neurons and glia with a Polr2a-based and cre-dependent GCaMP5G-IRES-tdTomato reporter mouse. Neuron 2014; 83(5): 1058–72.
- 25.↑
Dietrich A , Mederos YSM , Gollasch M , Gross V , Storch U , Dubrovska G , et al. Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol Cell Biol 2005; 25(16): 6980–9.
- 26.↑
Homolya L , Watt WC , Lazarowski ER , Koller BH , Boucher RC . Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice. J Biol Chem 1999; 274(37): 26454–60.
- 27.↑
Riquier-Brison ADM , Sipos A , Prókai Á , Vargas SL , Toma L , Meer EJ , et al. The macula densa prorenin receptor is essential in renin release and blood pressure control. Am J Physiol Renal Physiol 2018; 315(3): F521–f34.
- 28.↑
Gyarmati G , Shroff UN , Riquier-Brison A , Kriz W , Kaissling B , Neal CR , et al. A new view of macula densa cell microanatomy. Am J Physiol Renal Physiol 2021; 320(3): F492–f504.
- 29.↑
Kang JJ , Toma I , Sipos A , McCulloch F , Peti-Peterdi J . Quantitative imaging of basic functions in renal (patho)physiology. Am J Physiol Renal Physiol 2006; 291(2): F495–502.
- 30.↑
Shroff UN , Schiessl IM , Gyarmati G , Riquier-Brison A , Peti-Peterdi J . Novel fluorescence techniques to quantitate renal cell biology. Methods Cell Biol 2019; 154: 85–107.
- 31.↑
Peti-Peterdi J , Sipos A . A high-powered view of the filtration barrier. J Am Soc Nephrol 2010; 21(11): 1835–41.
- 32.↑
Peti-Peterdi J . Calcium wave of tubuloglomerular feedback. Am J Physiol Renal Physiol 2006; 291(2): F473–80.
- 33.↑
Schaldecker T , Kim S , Tarabanis C , Tian D , Hakroush S , Castonguay P , et al. Inhibition of the TRPC5 ion channel protects the kidney filter. J Clin Invest 2013; 123(12): 5298–309.
- 34.↑
Spires D , Ilatovskaya DV , Levchenko V , North PE , Geurts AM , Palygin O , et al. Protective role of Trpc6 knockout in the progression of diabetic kidney disease. Am J Physiol Renal Physiol 2018; 315(4): F1091–f7.
- 35.↑
Neal CR , Arkill KP , Bell JS , Betteridge KB , Bates DO , Winlove CP , et al. Novel hemodynamic structures in the human glomerulus. Am J Physiol Renal Physiol 2018; 315(5): F1370–f84.
- 36.↑
Matsusaka T , Sandgren E , Shintani A , Kon V , Pastan I , Fogo AB , et al. Podocyte injury damages other podocytes. J Am Soc Nephrol 2011; 22(7): 1275–85.
- 37.↑
Okabe M , Yamamoto K , Miyazaki Y , Motojima M , Ohtsuka M , Pastan I , et al. Indirect podocyte injury manifested in a partial podocytectomy mouse model. Am J Physiol Renal Physiol 2021; 320(5): F922–f33.
- 38.↑
Maier T , Follmann M , Hessler G , Kleemann HW , Hachtel S , Fuchs B , et al. Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels. Br J Pharmacol 2015; 172(14): 3650–60.
- 39.↑
Ilatovskaya DV , Palygin O , Levchenko V , Staruschenko A . Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli. Am J Physiol Cell Physiol 2013; 305(10): C1050–9.
- 40.↑
Gyarmati G , Jacob CO , Peti-Peterdi J . New endothelial mechanisms in glomerular (Patho)biology and proteinuria development captured by intravital multiphoton imaging. Front Med (Lausanne) 2021; 8: 765356.